Src kinase activation: A switched electrostatic network

Protein Science

Volumn 15, Issue 5, 2006, Pages 1051-1062

  Ozkirimli, Elif ^a   Post, Carol Beth ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Activated molecular dynamics; Allosterism; Enzyme activation; Phosphoproteins; Protein electrostatics

Indexed keywords

PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE;

ALPHA HELIX; ARTICLE; CONFORMATIONAL TRANSITION; DOWN REGULATION; ELECTRICITY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME STRUCTURE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; REACTION ANALYSIS;

CATALYTIC DOMAIN; COMPUTER SIMULATION; ELECTROSTATICS; ENZYME ACTIVATION; ENZYME STABILITY; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SRC-FAMILY KINASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33646146412     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.051999206     Document Type: Article

References (69)

1. Adams, J.A. 2003. Activation loop phosphorylation and catalysis in protein kinases: Is there functional evidence for the autoinhibitor model? Biochemistry 42: 601-607.
2. Banavali, N. and Roux, B. 2005. The N-terminal end of the catalytic domain of Src kinase Hck is a conformational switch implicated in long-range allosteric regulation. Structure 13: 1715-1723.
3. Barker, S., Kassel, D., Weigl, D., Huang, X., Luther, M., and Knight, W. 1995. Characterization of pp60c-Src tyrosine kinase activities using a continuous assay: Autoactivation of the enzyme is an intermolecular autophosphorylation process. Biochemistry 34: 14843-14851.
4. Boggon, T. and Eck, M.J. 2004. Structure and regulation of Src family kinases. Oncogene 23: 7918-7927.
5. Bolen, J.B. and Brugge, J.S. 1997. Leukocyte protein tyrosine kinases: Potential targets for drug discovery. Annu. Rev. Immunol. 15: 371-404.
6. Breitenlechner, C., Kairies, N., Honold, K., Scheiblich, S., Koll, H., Greiter, E., Koch, S., Shafer, W., Huber, R., and Engh, R. 2005. Crystal structures of active Src kinase domain complexes. J. Mol. Biol. 353: 222-231.
7. Brooks, B.R., Bruccoleri, R.E., Olafson, B.D., States, D.J., Swaminathan, S., and Karplus, M. 1983. CHARMM: A program for macromolecular energy minimization, and dynamics calculations. J. Comput. Chem. 4: 187-217.
8. Bryant, Z., Pande, V., and Rokhsar, D. 2000. Mechanical unfolding of a β-hairpin using molecular dynamics. Biophys. J. 78: 584-589.
9. Burkhardt, A., Brunswick, M., Bolen, J., and Mond, J. 1991. Anti-immunoglobulin stimulation of B lymphocytes activates Src-related tyrosine kinases. Proc. Natl. Acad. Sci. 88: 7410-7414.
10. Capdeville, R., Buchdunger, E., Zimmermann, J., and Matter, A. 2002. Glivec (sti571, imatinib), a rationally developed, targeted anticancer drug. Nat. Rev. Drug Discov. 1: 493-502.
11. Chan, V.W.F., Meng, F., Soriano, P., DeFranco, A.L., and Lowell, C. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and downregulation. Immunity 7: 69-81.
12. Chan, V.W.F., Lowell, C.A., and DeFranco, A.L. 1998. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8: 545-553.
13. Cowan-Jacob, S., Fendrich, G., Manley, P., Jahnke, W., Fabbro, D., Liebetanz, J., and Meyer, T. 2005. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. Structure 13: 861-871.
14. Daggett, V. and Levitt, M. 1992. Molecular dynamics simulations of helix denaturation. J. Mol. Biol. 223: 1121-1138.
15. Darden, T., York, D., and Pedersen, L. 1993. Particle mesh ewald (pme): A nlog(n) method for ewald sums in large systems. J. Chem. Phys. 98: 10089-10092.
16. Diaz, J.F., Wroblowski, B., Schlitter, J., and Engelborghs, Y. 1997. Calculation of pathways for the conformational transition between the GTP- and GDP-bound states of the Ha-ras-p21 protein: Calculations with explicit solvent simulations and comparison with calculations in vacuum. Proteins 28: 434-451.
17. Feng, M.-H., Philippopoulos, M., MacKerell Jr., A., and Lim, C. 1996. Structural characterization of the phosphotyrosine binding region of a high-affinity SH2 domain-phosphopeptide complex by molecular dynamics simulation and chemical shift calculations. J. Am. Chem. Soc. 118: 11265-11277.
18. Gaul, B.S., Harrison, M.L., Geahlen, R.L., Burton, R.K., and Post, C.B. 2000. Substrate recognition by the Lyn protein-tyrosine kinase: NMR structure of the immunoreceptor tyrosine-based activation motif signaling region of the B cell antigen receptor. J. Biol. Chem. 275: 16174-16182.
19. Gibbs, C.S. and Zoller, M.J. 1991. Rational scanning mutagenesis of a proteinkinase identifies functional regions involved in catalysis and substrate interactions. J. Biol. Chem. 266: 8923-8931.
20. Hong, J., Yankee, T., Harrison, M., and Geahlen, R. 2002. Regulation of signaling in B cells through the phosphorylation of Syk on linker region tyrosines. J. Biol. Chem. 277: 31703-31714.
21. Hoover, W. 1985. Canonical dynamics: Equilibrium phase-space distribution. Phys. Rev. A 31: 1695-1697.
22. Humphrey, W., Dalke, A., and Schulten, K. 1996. VMD: Visual molecular dynamics. J. Mol. Graph. 14: 33-38.
23. Isralewitz, B., Baudry, J., Gullingsrud, J., Kosztin, D., and Schulten, K. 2001a. Steered molecular dynamics investigations of protein function. J. Mol. Graph. Model. 19: 13-25.
24. Isralewitz, B., Gao, M., and Schulten, K. 2001b. Steered molecular dynamics and mechanical functions of proteins. Curr. Opin. Struct. Biol. 11: 224-230.
25. Jorgensen, W. 1981. Transferable intermolecular potential functions for water, alcohols and ethers. application to liquid water. J. Am. Chem. Soc. 103: 335-340.
26. Kamps, M. and Sefton, B.M. 1986. Neither arginine nor histidine can carry out the function of Lys295 in the ATP-binding site of p60-Src. Mol. Cell. Biol. 6: 751-757.
27. Knighton, D.R., Zheng, J.H., Ten Eyck, L.F., Ashford, V.A., Xuong, N.H., Taylor, S.S., and Sowadski, J.M. 1991. Crystal structure of the catalytic subunit of cyclic adenosine-monophosphate dependent protein-kinase. Science 253: 407-414.
28. Krause, D. and Van Etten, R. 2005. Tyrosine kinases as targets for cancer therapy. N. Engl. J. Med. 353: 172-187.
29. Kwak, E.L., Sordella, R., Bell, D.W., Godin-Heymann, N., Okimoto, R.A., Brannigan, B.W., Harris, P.L., Driscoll, D.R., Fidias, P., Lynch, T.J., et al. 2005. Irreversible inhibitors of the egf receptor may circumvent acquired resistance to gefitinib. Proc. Natl. Acad. Sci. 102: 7665-7670.
30. Lazaridis, T. and Karplus, M. 1999. Effective energy function for proteins in solution. Proteins 35: 133-152.
31. Li, Y., Zhou, Z., and Post, C.B. 2005. Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid. Proc. Natl. Acad. Sci. 102: 7529-7534.
32. Lowell, C.A. and Soriano, P. 1996. Knockouts of Src-family kinases: Stiff bones, wimpy T cells, and bad memories. Genes & Dev. 10: 1845-1857.
33. Lowell, C.A., Soriano, P., and Varmus, H.E. 1994. Functional overlap in the Src gene family - Inactivation of Hck and Fgr impairs natural immunity. Genes & Dev. 8: 387-398.
34. Lutz, M., Esser, I., Flossmann-Kast, B., Vogelmann, R., Luhrs, H., Friess, H., Buchler, M., and Adler, G. 1998. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem. Biophys. Res. Commun. 243: 503-508.
35. Ma, J. and Karplus, M. 1997. Molecular switch in signal transduction: Reaction paths of the conformational changes in ras p21. Proc. Natl. Acad. Sci. 94: 11905-11910.
36. Ma, J., Sigler, P.B., Xu, Z., and Karplus, M. 2000. A dynamic model for the allosteric mechanism of GroEL. J. Mol. Biol. 302: 303-313.
37. MacKerell Jr., A.D., Bashford, D., Bellott, M., Dunbrack Jr., R., Evanseck, J., Field, M., Fischer, S., Gao, J., Guo, H., Ha, S., et al. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102: 3586-3616.
38. Marchi, M. and Ballone, P. 1999. Adiabatic bias molecular dynamics: A method to navigate the conformational space of complex molecular systems. J. Chem. Phys. 110: 3697-3702.
39. McLaughlin, S. and Aderem, A. 1995. The myristoyl-electrostatic switch: A modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20: 272-276.
40. Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C., Kuriyan, J., and Miller, T. 1997. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385: 650-653.
41. Morra, G., Hodoscek, M., and Knapp, E. 2003. Unfolding of the cold shock protein studied with biased molecular dynamics. Proteins 53: 597-606.
42. Neria, E., Fischer, S., and Karplus, M. 1996. Simulation of activation free energies in molecular systems. J. Chem. Phys. 105: 1902-1921.
43. Nishizumi, H., Horikawa, K., Mlinaric-Rascan, I., and Yamamoto, T. 1998. A double-edged kinase Lyn: A positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 187: 1343-1348.
44. Noble, M.E.M., Endicott, J.A., and Johnson, L.N. 2004. Protein kinase inhibitors: Insights into drug design from structure. Science 303: 1800-1805.
45. Paci, E. and Karplus, M. 1999. Forced unfolding of fibronectin type 3 modules: An analysis by biased molecular dynamics simulations. J. Mol. Biol. 288: 441-459.
46. Paci, E., Caflisch, A., Pluckthun, A., and Karplus, M. 2001. Forces and energetics of hapten-antibody dissociation: A biased molecular dynamics sudy. J. Mol. Biol. 314: 589-605.
47. Porter, M., Schindler, T., Kuriyan, J., and Miller, W.T. 2000. Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416): Effect of introducing a high affinity intramolecular SH2 ligand. J. Biol. Chem. 275: 2721-2726.
48. Rost, B. 1999. Twilight zone of protein sequence alignments. Protein Eng. 12: 85-94.
49. Sali, A. and Blundell, T.L. 1993. Comparative protein modeling by satisfaction of spatial restraints. J. Mol. Biol. 234: 779-815.
50. Schindler, T., Sicheri, F., Pico, A., Gazit, A., Levitzki, A., and Kuriyan, J. 1999. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3: 639-648.
51. Schindler, T., Bornmann, W., Pellicana, P., Miller, W.T., Clarkson, B., and Kuriyan, J. 2000. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 289: 1938-1942.
52. Schlitter, J., Engels, M., Kruger, P., Jacoby, E., and Wollmer, A. 1993. Targeted molecular dynamics simulation of conformational change: Application to the T-R transition in insulin. Mol. Simul. 10: 291-308.
53. Shaffer, J. and Adams, J.A. 1999. Detection of conformational changes along the kinetic pathway of protein kinase A using a catalytic trapping technique. Biochemistry 38: 12072-12079.
54. Sicheri, F. and Kuriyan, J. 1997. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7: 777-785.
55. Sicheri, F., Moarefi, I., and Kuriyan, J. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602-609.
56. Smith, K.G.C., Tarlinton, D.M., Doody, G.M., Hibbs, M.L., and Fearon, D.T. 1998. Inhibition of the B cell by CD22: A requirement for Lyn. J. Exp. Med. 187: 807-811.
57. Snyder, M., Bishop, J., McGrath, J., and Levinson, A. 1985. A mutation at the ATP-binding site of pp60v-src abolishes kinase activity, transformation, and tumorigenicity. Mol. Cell. Biol. 5: 1772-1779.
58. Süel, G., Lockless, S., Wall, M., and Ranganathan, R. 2003. Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat. Struct. Biol. 10: 59-69.
59. Thomas, S.M. and Brugge, J.S. 1997. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13: 513-609.
60. Verbeek, B., Vroom, T., Adriaansen-Slot, S., Ottenhoff-Kalff, A., Geertzema, J., Hennipman, A., and Rijksen, G. 1996. c-Src protein expression is increased in human breast cancer. An immunochemical and biochemical analysis. J. Pathol. 180: 383-388.
61. Volkman, B., Lipson, D., Wemmer, D., and Kern, D. 2001. Two-state allosteric behavior in a single-domain signaling protein. Science 291: 2429-2433.
62. Williams, J., Weijland, A., Gonfloni, S., Thompson, A., Courtneidge, S., Superti-Furga, G., and Wierenga, R. 1997. The 2.35 crystal structure of the inactivated form of chicken Src: A dynamic molecule with multiple regulatory interactions. J. Mol. Biol. 274: 757-775.
63. Xu, W., Harrison, S., and Eck, M.J. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385: 595-602.
64. Xu, W., Doshi, A., Lei, M., Eck, M.J., and Harrison, S.C. 1999. Crystal structure of c-Src reveals features of its autoinhibitory mechanism. Mol. Cell 3: 629-638.
65. Yamaguchi, H. and Hendrickson, W.A. 1996. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384: 484-489.
66. Yamanashi, Y., Kakiuchi, T., Mizuguchi, J., Yamamoto, T., and Toyoshima, K. 1991. Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science 251: 192-194.
67. Young, M.A., Gonfloni, S., Superti-Furga, G., Roux, B., and Kuriyan, J. 2001. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell 105: 115-126.
68. Zheng, W., Brooks, B.R., Doniach, S., and Thirumalai, D. 2005. Network of dynamically important residues in the open/closed transition in polymerases is strongly conserved. Structure 13: 565-577.
69. Zhu, X., Kim, J., Newcomb, J., Rose, P., Stover, D., Toledo, L., Zhao, H., and Morgenstern, K. 1999. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Structure 7: 651-661.